ATS 2024 Final Program

Click on the session title to view the speakers

SUNDAY • MAY 19

67

P92 Not All Alveolar Hemorrhage Is Autoimmune in Nature. A Case of Menthol-Related Pneumonitis Complicated by Alveolar Hemorrhage P93 Rapid, Progressive Nodular-appearing CT Changes: A Unique Presentation of EVALI P94 Can You Recognize Me? A Case of Organizing Pneumonia and E-cigarette, or Vaping Associated Lung Injury P95 E-Cigarettes and Vaping Devices - The New Pulmonary Villains on the Block P96 Crisis in the Lungs: EVALI Unveiled in a Young Male Patient P97 Recurrent Primary Spontaneous Pneumothoraces Associated With High Frequency E-cigarette Use in a 19-year-old Male: A Case Report P98 First Known Case Report of Vaping-Induced Pneumomediastinum in a Human Immunodeficiency Virus Patient P99 A Breathless Encounter: Pneumothorax in an Ehlers-danlos Syndrome Patient Due to E-cigarette Overuse P100 Vaping and VATS: Pneumothorax, Fibrosis and Emphysema in a Young Healthy Male P101 A Rare Case of Spontaneous Pneumomediastinum Secondary to Vaping in Asthma Exacerbation P102 A Rare Case: Pulmonary Embolism Caused by Hookah in a Young Woman P103 Pulmonary Embolism in a Chronic Nitrous Oxide Abuser: The Role of Homocysteine and Vitamin B12 Deficiency in Venous Thromboembolism P104 Breathing Life into Differential Diagnosis: Cocaine-induced Pneumomediastinum P105 Acute Methamphetamine-Induced Alveolar Hemorrhage: A Case Report P106 IVDU, I Can’t Hear You: Sudden Hearing Loss After Fentanyl Use P107 Zieve Syndrome: A Rare Cause of Hemolytic Anemia in Alcohol Use Disorder P108 A Rare Case of a Bronchocutaneous Fistula After Xylazine Use P109 An Electronic Cigarette Pod System Delivering 6-methyl Nicotine, A Synthetic Nicotine Analog, Marketed in the United States as “PMTA Exempt”

CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

A56 BUZZING THE TOWER: NOVEL DIAGNOSTIC AND MONITORING TOOLS IN PH 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P593 Development of a High-Quality Assessment Instrument for a Novel Pulmonary Hypertension Curriculum P594 Efficacy of Ventilation-perfusion Photo Emission Computed Tomography/Computed Tomography for Classifying Pulmonary Hypertension P595 Functional Respiratory Imaging and Rapid Deposition Analysis Predict Enhanced Lung Deposition of Imatinib With the AER-901 Inhalation System in Pulmonary Hypertension P596 SPECT ERNA: Providing a Different View on Ventricular Volumes in Pulmonary Arterial Hypertension P597 Breath Analysis as a Prognostication Tool in Pulmonary Hypertension P598 Plasma Catecholamines in Patients With Unexplained Dyspnea Undergoing Invasive Cardiopulmonary Exercise Testing With or Without Preload Insufficiency P599 Assessment of Submaximal Cardiopulmonary Hemodynamics in Patients With Exercise Pulmonary Hypertension P600 Respiratory Variability of Pulmonary Arterial and Pulmonary Capillary Wedge Pressure as a Measure for Intrathoracic Pressure in Group I Pulmonary Hypertension Patients With Obesity P601 Getting More Out of the 6-minute Walk Test Through Metabolic and Heart Rate Monitoring San Diego Convention Center Area F (Hall A-B2, Ground Level)

ATS 2024 Conference Program • San Diego, CA